Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

Abstract excerpt

Thrombotic microangiopathy (TMA), characterized by organ injury occurring consequent to severe endothelial damage, can manifest in a diverse range of diseases. In complement-mediated atypical haemolytic uraemic syndrome (aHUS) a primary defect in complement, such as a mutation or autoantibody leading to over activation of the alternative pathway, predisposes to the development of disease, usually following...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Complement system in diseases
• Share to Hemoglobinopathies and Related Disorders
• Share to Renal Diseases and Glomerulopathies